Teva Pharmaceutical (Germany) Analysis
| TEV Stock | EUR 21.20 0.70 3.41% |
Teva Pharmaceutical Industries is overvalued with Real Value of 15.98 and Hype Value of 21.2. The main objective of Teva Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Teva Pharmaceutical Industries is worth, separate from its market price. There are two main types of Teva Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Teva Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Teva Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Teva Pharmaceutical stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Teva Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
Teva |
Teva Stock Analysis Notes
About 50.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.16. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teva Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.75. The entity recorded a loss per share of 1.96. The firm last dividend was issued on the 27th of November 2017. Teva Pharmaceutical had 100:1 split on the 1st of July 2004. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel. TEVA PHARMACEUT operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 42535 people. To find out more about Teva Pharmaceutical Industries contact Kare Schultz at 972 3 914 8213 or learn more at https://www.tevapharm.com.Teva Pharmaceutical Investment Alerts
| Teva Pharmaceutical appears to be risky and price may revert if volatility continues | |
| Teva Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| Teva Pharmaceutical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Teva Pharmaceutical Industries has accumulated 19.1 B in total debt with debt to equity ratio (D/E) of 184.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Teva Pharmaceutical has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Teva Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Teva Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Teva Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Teva to invest in growth at high rates of return. When we think about Teva Pharmaceutical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 6.97 B. |
Teva Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 10.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Teva Pharmaceutical's market, we take the total number of its shares issued and multiply it by Teva Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Teva Profitablity
Teva Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Teva Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Teva Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Teva Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Teva Pharmaceutical's profitability requires more research than a typical breakdown of Teva Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18. Technical Drivers
As of the 22nd of December, Teva Pharmaceutical has the Coefficient Of Variation of 694.24, semi deviation of 1.46, and Risk Adjusted Performance of 0.1219. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teva Pharmaceutical, as well as the relationship between them. Please validate Teva Pharmaceutical mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and information ratio to decide if Teva Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 21.2 per share.Teva Pharmaceutical Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Teva Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Teva Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Teva Pharmaceutical Outstanding Bonds
Teva Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Teva Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Teva bonds can be classified according to their maturity, which is the date when Teva Pharmaceutical Industries has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| TEVA 5125 09 MAY 29 Corp BondUS88167AAQ40 | View | |
| TEVA 475 09 MAY 27 Corp BondUS88167AAP66 | View | |
| US88167AAN19 Corp BondUS88167AAN19 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| TEVA 8125 15 SEP 31 Corp BondUS88167AAR23 | View |
Teva Pharmaceutical Predictive Daily Indicators
Teva Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Teva Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Teva Pharmaceutical Forecast Models
Teva Pharmaceutical's time-series forecasting models are one of many Teva Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teva Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Teva Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Teva Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Teva shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Teva Pharmaceutical. By using and applying Teva Stock analysis, traders can create a robust methodology for identifying Teva entry and exit points for their positions.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel. TEVA PHARMACEUT operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 42535 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Teva Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Complementary Tools for Teva Stock analysis
When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |